Protecting Patients with Cirrhosis from COVID-19: Identifying Gaps in Vaccination Rates.

Overview

The SARS-CoV2 pandemic has resulted in the deaths of more than 600,000 Americans to date, and millions more worldwide. The rapid development of multiple vaccines with exceedingly high (>90%) efficacy at preventing death from SARS-CoV2 is one of the recent miracles of medicine. Early vaccination efforts targeted those with the highest risk of contracting and/or dying from SARS-CoV2, including the elderly and those with chronic medical conditions (e.g., cancer, immunosuppression).

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society Journal